Home › Compare › SIOPF vs MRK

SIOPF vs MRK: Dividend Comparison 2026

SIOPF yields 7905.14% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SIOPF wins by $5458.89M in total portfolio value
10 years
SIOPF
SIOPF
● Live price
7905.14%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5458.95M
Annual income
$206,140,538.48
Full SIOPF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SIOPF vs MRK

📍 SIOPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSIOPFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SIOPF + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SIOPF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SIOPF
Annual income on $10K today (after 15% tax)
$671,936.76/yr
After 10yr DRIP, annual income (after tax)
$175,219,457.71/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SIOPF beats the other by $175,211,129.30/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SIOPF + MRK for your $10,000?

SIOPF: 50%MRK: 50%
100% MRK50/50100% SIOPF
Portfolio after 10yr
$2729.50M
Annual income
$103,075,168.31/yr
Blended yield
3.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SIOPF
No analyst data
Altman Z
-0.2
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SIOPF buys
0
MRK buys
0
No recent congressional trades found for SIOPF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSIOPFMRK
Forward yield7905.14% ✓2.76%
Annual dividend / share$2.00$3.32 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7% ✓
Portfolio after 10y$5458.95M ✓$56.8K
Annual income after 10y$206,140,538.48 ✓$9,798.13
Total dividends collected$4311.20M ✓$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SIOPF vs MRK ($10,000, DRIP)

YearSIOPF PortfolioSIOPF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$405,957$395,256.92$11,206$366.19+$394.8K → SIOPF
2$7,932,378$7,498,003.71$12,650$502.35+$7.92M → SIOPF
3$76,950,547$68,462,903.31$14,407$694.19+$76.94M → SIOPF
4$392,685,744$310,348,658.26$16,585$967.82+$392.67M → SIOPF
5$1,160,238,158$740,064,411.78$19,342$1,363.89+$1160.22M → SIOPF
6$2,263,235,673$1,021,780,844.14$22,913$1,947.19+$2263.21M → SIOPF
7$3,353,041,550$931,379,379.54$27,662$2,823.89+$3353.01M → SIOPF
8$4,232,549,962$644,795,503.82$34,159$4,173.35+$4232.52M → SIOPF
9$4,909,167,919$380,339,459.82$43,337$6,308.80+$4909.12M → SIOPF
10$5,458,950,212$206,140,538.48$56,776$9,798.13+$5458.89M → SIOPF

SIOPF vs MRK: Complete Analysis 2026

SIOPF — Stock

Shimao Group Holdings Limited, an investment holding company, engages in the property development and investment activities in the People's Republic of China. The company develops residential and commercial properties; and operates hotels and shopping malls. It is also involved in the trading of construction materials; and property management activities. The company was formerly known as Shimao Property Holdings Limited and changed its name to Shimao Group Holdings Limited in May 2020. Shimao Group Holdings Limited was incorporated in 2004 and is based in Hong Kong, Hong Kong. Shimao Group Holdings Limited operates as a subsidiary of Gemfair Investments Limited.

Full SIOPF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SIOPF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SIOPF vs SCHDSIOPF vs JEPISIOPF vs OSIOPF vs KOSIOPF vs MAINSIOPF vs JNJSIOPF vs ABBVSIOPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.